Mar 24 2023
Press release from the Extraordinary General Meeting in Vimian Group AB (publ) on 24 March 2023
Vimian held its Extraordinary General Meeting today 24 March 2023. The Extraordinary General Meeting in Vimian resolved the following:
The Extraordinary General Meeting resolved, with the required majority, in accordance with the Board of Directors’ proposal, to carry out an issue of not more than 15,502,391 new ordinary shares, entailing an increase in the share capital of not more than SEK 25,852.660492, to partly finance the company’s acquisition of Viking Blues Pty Ltd. The right to subscribe for new shares shall only vest in Finn Pharmaceuticals Pty Limited as trustee for Finn Pharmaceuticals Trust, against payment by transfer of 36,519,732 shares in Viking Blues Pty Ltd.
The value of the contribution in kind as specified in the report by the Board of Directors pursuant to Chapter 13, Section 7 of the Swedish Companies Act corresponds to a subscription price of SEK 24.30 per share.
For further information about the resolution, refer to the minutes of the Extraordinary General Meeting, which will be available on the company’s website, www.vimian.com, no later than two weeks after the Extraordinary General Meeting.